期刊文献+

成人急性髓系白血病M2型免疫表型分析 被引量:1

Multiparametric immunophenotypic features of acute myeloid leukemia-M2 in adult patients
原文传递
导出
摘要 目的 :探讨成人急性髓系白血病M2型(acute myeloid leukemia-type M2,AML-M2)白血病细胞免疫表型的特征及临床意义。方法 :采用多参数FCM和CD45/侧向角散射(side scatter,SSC)设门,对93例AML-M2患者的白血病细胞进行免疫表型分析。结果 :93例AML-M2患者骨髓白血病细胞表达髓系祖细胞抗原CD117(91.4%)、CD34(80.6%)和HLA-DR(46.2%)及髓系相关抗原CD13(86.0%)、CD33(67.7%)和CD71(50.5%)。部分患者伴有淋系分化抗原的表达,CD7阳性表达率最高(31.2%),其次为CD56(25.8%)。17例RUNX 1-RUNX 1T 1融合基因阳性AML-M2患者白血病细胞阳性表达率最高的抗原为CD34(76.4%),其次为CD33(70.6%)、CD117(70.6%)和CD13(52.9%)。76例RUNX1-RUNX1T1融合基因阴性AML-M2患者白血病细胞高表达CD117(96.1%)、CD13(93.4%)、CD34(81.6%)、CD33(67.1%)和CD71(55.3%)。在RUNX 1-RUNX 1T 1融合基因阳性患者中,阳性表达率最高的淋系分化抗原为CD56(47.1%);在RUNX1-RUNX 1T 1融合基因阴性患者中,阳性表达率最高的淋系分化抗原为CD7(35.5%)。RUNX1-RUNX1T1融合基因阳性患者的CD117、CD13和CD71阳性表达率低于RUNX 1-RUNX 1T 1融合基因阴性患者(P值均<0.05),而CD38和CD56阳性表达率均高于RUNX1-RUNX1T1融合基因阴性患者(P值均<0.05)。结论 :AML-M2白血病细胞抗原表达复杂,异质性强,强表达髓系相关抗原并常伴有淋系分化抗原的表达。RUNX1-RUNX1T1融合基因阳性与阴性AML-M2患者表现出不同的免疫表型特征。 Objective:To investigate the immunophenotypic features of leukemia cells in patients with acute myeloid leukemia-type M2(AML-M2) and its clinical significance.Methods:CD45/side scatter(SSC) gating strategy of FCM was used to determine immunophenotyping of leukemia cells in 93 patients with AML-M2.Results:The expression rates of hematopoietic stem/progenitor cell differentiation antigens,such as CD 117(91.4%),CD 34(80.6%) and HLA-DR(46.2%),were high.The myeloidassociated antigens of CD13(86.0%),CD33(67.7%) and CD71(50.5%) were also highly expressed.In some patients,lymphoid-associated antigens were expressed,in which,the positive expression rate of CD7(31.2%) was highest,followed by CD56(25.8%).In17 RUNX1-RUNX1T1-positive patients,the positive expression rate of CD34(76.4%)was highest,followed by CD33(70.6%),CD117(70.6%) and CD13(52.9%).In 76 RUNX1-RUNX1T1-negative patients,the positive expression rates of CD117(96.1%),CD13(93.4%),CD34(81.6%),CD33(67.1%) and CD71(55.3%) were high.Of lymphoid-associated antigens,the positive expression rate of CD56(47.1%) was highest in RUNX1-RUNX1T1-positive patients,and the positive expression rate of CD7(35.5%) was highest in RUNX1-RUNX1T1-negative patients.The positive expression rates of CD117,CD13 and CD71 were lower and the positive expression rates of CD38 and CD56 were higher in RUNX1-RUNX1T1-positive patients than those in RUNX1-RUNX1T1-negative patients(all P 〈 0.05).Conclusion:The antigen expression in AML-M2 is complicated with high heterogeneity,mainly presented with high expression of myeloid-associated antigens and expression of lymphoidassociated antigens.The immunophenotypic features between RUNX1-RUNX1T1-positive and-negative AML-M2 patients are different.
出处 《肿瘤》 CAS CSCD 北大核心 2016年第3期319-325,共7页 Tumor
关键词 急性髓系白血病 M2型 多参数FCM 免疫表型 Acute myeloid leukemia,type M2 Multiparameter FCM Immunophenotyping
  • 相关文献

参考文献12

  • 1Estey E, Dohner H. Acute myeloid leukaemia[J]. Lancet, 2006, 368(9550):1894-1907.
  • 2潘湘涛,李建勇,夏学鸣,薛永权.MIC分型评价成人急-性髓系白血病中的淋系抗原表达[J].肿瘤,2006,26(10):944-946. 被引量:12
  • 3Swerdllow SH, Campo E, Harris NL, eta/. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues[M]. 4th ed. Lyon: IARC Press, 2008:110-130.
  • 4Weinberg OK, Pozdnyakova O, Campigotto F, eta/. Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemiaU]. Mod Patho/, 2015, 28(7):965-976.
  • 5Suzuki R, Ohtake S, Takeuchi J, eta/. The clinical characteristics of CD7+CD56+ acute myeloid leukemias other than M0[J]. IntJ Hematol, 2010, 91(2):303-309.
  • 6Krauth MT, Eder C, Alpermann T, et al. High number of additional genetic lesions in acute myeloid leukemia with t(8;21 )/RUNXl -RUNXl T1 : frequency and impact on clinical outcome[J]. Leukemia, 2014, 28(7): 1449-1458.
  • 7Pullarkat ST, Pullarkat V, Lagoo A, et al. Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1 -RUNXl T1 [J]. Leuk Res, 2013, 37(11):1572-1575.
  • 8郭睿,沈安俐,王琰,刘露,张建富,王蓉,李建勇,吴雨洁.CD56阳性急性髓系白血病患者的免疫表型分析[J].中国实验血液学杂志,2015,23(5):1231-1234. 被引量:8
  • 9Ding B, Zhou L, Jiang X, et al.The relationship between clinical feature, complex immunophenotype, chromosome karyotype, and outcome of patients with acute myeloid leukemia in China[J]. Dis Markers, 2015,2015:382186.
  • 10Sarma A, Hazarika M, Das D, et al. Expression of aberrant CD markers in acute leukemia: a study of 100 cases with immunophenotyping by multiparameter flowcytometry[J]. CancerBiornark, 2015, 15(4):501-505.

二级参考文献26

  • 1王慧萍,李国霞,乔振华,王宏伟.MICM分型诊断在鉴别M_2和M_3型急性髓性白血病中的意义[J].临床血液学杂志,2005,18(2):89-91. 被引量:8
  • 2汤美华,周宇,沈德诚,卞寿庚,钱林生,王琦,王志澄,陈璋.从AML细胞表面标记特点看AML、ALL鉴别时髓系单抗的选择[J].中华血液学杂志,1994,15(9):466-468. 被引量:12
  • 3肖志坚,郝玉书,李建波,冯宝章,徐丽娟,李幼升,汤美华,王建祥.t(8;21)急性髓细胞白血病──30例临床和实验室分析[J].中华血液学杂志,1995,16(4):190-192. 被引量:8
  • 4FELICETTO F,ROSA N,MARIO A,et al.Immunophenotypic analysis enables the correct prediction of t(8;21) in acute myeloid leukemia[J].Br J Haematol,1998,102(2):444-448.
  • 5ARBER D A,STEIN A S,CARTER N H,et al.Prognostic impact of acute myeloid leukemia classification.Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival[J].AM J Clin Pathol,2003,119 (5):672-680.
  • 6JENNING C D,FOON K A.Recent advances in flow cytometry:Application to the diagnosis of hematologic malignancy[J].Blood,1997,80(8):2863-2892.
  • 7Nucifora G,Birn DJ,Erickson P,et al.Detection of DNA rearrangements in the MALl and ETO loci and of an AML1/ETO fusion mNRA in patient with t (8; 21) acute myeloid leukemia.Blood,1993; 81:883 -888
  • 8Andrieu V,Radford-Weiss I,Troussard X,et al.Molecular detection of t (8; 21)/AML1-ETO in AML M1/M2:correlation with cytogenetics,morphology and immunophenotype.Br J Haematol,1996; 92:855-865
  • 9Cho EK,Bang SM,Ahn JY,et al.Prognostic value of AML1/ETO fusion transcripts in patients with acute myelogenous leukemia.Korean J Intern Med,2003; 18:13 -20
  • 10Kita K,Nakase K,Miwa H,et al.Phenotypical characteristics of acute myelocytic leukemia associated with the t(8 ;21) (q22 ;q22) chromosomal abnormality:frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34.Blood,1992;80:470-477.

共引文献26

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部